BioSpace News Archive

Drug Development

MyoKardia Publishes Data in Nature Digital Medicine Showing Potential of Wrist-Worn Biosensor to Screen for Hypertrophic Cardiomyopathy

Continuous Monitoring with Wearable Device Detected Distinct Pulse Wave Patterns in Obstructive Hypertrophic Cardiomyopathy Patients as Compared to Healthy Volunteers

June 24, 2019
·
5 min read
Drug Development

Bristol-Myers Squibb’s Opdivo Fails to Show Superiority to Bayer’s Nexavar in Liver Cancer

The drug failed to meet statistical significance for overall survival. However, the company is putting a positive spin on it, saying it showed a clear improvement trend in OS for patients treated with Opdivo compared to sorafenib.

June 24, 2019
·
2 min read
·
Mark Terry
Deals

Bristol-Myers Squibb Plans to Sell Celgene’s Otezla in Attempt to Expedite Acquisition

“Bristol-Myers Squibb is committed to working with regulatory authorities around the world on the proposed combination with Celgene,” the company stated. “The company is focused on realizing the promise of the transaction, and is continuing to work to complete the transaction on a timely basis.”

June 24, 2019
·
2 min read
·
Mark Terry
Policy

Glenmark Works to Address Concerns in FDA’s CRL and Gain Approval for Ryaltris

Glenmark said it should be able to resolve the FDA’s concerns within six to nine weeks and will work with the regulatory agency toward approval.

June 24, 2019
·
2 min read
·
Alex Keown
Drug Development

AbbVie Resumes Multiple Myeloma Trial After FDA Lifts Partial Hold

The partial clinical hold was lifted after the company revised the study protocol for the trial. The partial clinical hold remains on other multiple myeloma trials involving venetoclax.

June 24, 2019
·
3 min read
·
Alex Keown
Pharm Country

New BTX 1801 data presented at ASM Microbe 2019

Botanix collaborator Dr Mark Blaskovich of the University of Queensland presented new antimicrobial data at ASM Microbe 2019, highlighting cannabidiol as a remarkably active Gram-Positive antibiotic

June 24, 2019
·
3 min read
Pharm Country

Enterin’s DEMET Study Enrolls First Patient With Parkinson’s Disease Dementia (PDD)

Enterin Inc., a CNS pharmaceutical company based in Philadelphia and developing novel compounds to treat Parkinson’s disease, has enrolled the first patient in the DEMET study.

June 24, 2019
·
2 min read
Business

MorphoSys Appoints Jean-Paul Kress, M.D., as New Chief Executive Officer

MorphoSys AG announced that its Supervisory Board has appointed Jean-Paul Kress, M.D., as its new Chief Executive Officer.

June 24, 2019
·
6 min read
Business

SCRS Announces SPRIA Asia-Pac Finalists

The Society for Clinical Research Sites announced the finalists for the 2019 Asia-Pac Site Patient Recruitment Innovation Award.

June 24, 2019
·
1 min read
Business

GENFIT and Terns Pharmaceuticals Announce $228MM Strategic Partnership to Develop and Commercialize Elafibranor in Greater China

GENFIT announced the signing of a licensing and collaboration agreement with Terns Pharmaceuticals, a global biopharmaceutical company based in the U.S. and China with a focus on developing novel and combination therapies to treat liver disease.

June 24, 2019
·
8 min read